Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Finance
Biotech products company reports second-quarter income of $12.1M
September 8th, 2004
Genencor International, Inc., (GCOR) reported that for the quarter ended June 30, 2004, net income available to common stockholders was $12.1 million, or $0.20 per diluted share, compared to $5.8 million or $0.10 per diluted share during the same period in 2003. Product revenues increased by 7% to $96.2 million, compared to $89.7 million in the second quarter of 2003. Total revenues in the second quarter were $109.9 million, compared to $96.3 million for the same period in 2003. Fees and royalty revenues were $13.8 million in the second quarter of 2004 as compared to $6.6 million in the prior year. For the second quarter of 2004, Genencor generated $17.5 million in...
Source: Vaccine Weekly (2004-09-08)
|
